Stocks/NBTX

Create a free account to see ACCE Scores

Sign up for free to unlock scores, score breakdowns, and stock analysis.

NBTX

↓ PDF (Pro)
Nanobiotix S.A. American Depositary Shares
HealthcareBiotechnologyFranceNASDAQ
$34.40
+10.40%today
MKT CAP
$2.0B
+7.6% · 1Y
Analyst Targets
Current price
$34.40
Low
$25.90
Analyst Mean
$34.23
High
$38.91
6 analystsStrong Buy
Full Financials
Trailing P/E-
Forward P/E234.5x
EV/EBITDA-213.9x
Price/Sales-
Dividend Yield-
Revenue Growth YoY-
Earnings Growth YoY-
Revenue Growth QoQ-
5y Revenue CAGR+89.7%
5y Earnings CAGR-
Gross Margin100.0%
Operating Margin-196.4%
Net Margin-73.5%
ROE-
Debt / Equity-
Free Cash Flow$-7,894,125
Insider Ownership0.0%
Institutional Ownership11.8%
Short % of Float0.03%
Days to Cover0.2d
1 Week+3.9%
1 Month-
3 Months-
6 Months-
YTD-
1 Year-
3 Years-
5 Years-
vs 50-day SMA-
vs 200-day SMA-
vs 52w High-
vs 52w Low-
Top Holders
HolderType% HeldValueΔ SharesAs of
Johnson & Johnsoninstitution11.59%$0.26B+0.00%2025-12-31
Morgan Stanleyinstitution0.05%$0.00B+863.96%2025-12-31
Millennium Management Llcinstitution0.03%$0.00B+100.00%2025-12-31
Optiver Holding B.v.institution0.03%$0.00B+202.93%2025-12-31
Marshall Wace LLPinstitution0.02%$0.00B+100.00%2025-12-31
BNP Paribas Financial Marketsinstitution0.01%$0.00B+800.00%2025-12-31
Royal Bank of Canadainstitution0.01%$0.00B+2000.00%2025-12-31
UBS Group AGinstitution0.01%$0.00B+263.20%2026-03-31
Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fundfund0.01%$0.00B+0.00%2026-02-28
Rhumbline Advisersinstitution0.00%$0.00B+6996.97%2025-12-31
Gamma Investing LLCinstitution0.00%$0.00B+261.57%2026-03-31
TickerCapScoreP/EFwd P/EEV/EBITDAROEGrossD/EDiv
PTGX
Protagonist Therapeutics Inc. Common Stock
$6.6B5------0.00%
CELC
Celcuity Inc. Common Stock
$6.7B5------0.00%
ACLX
Arcellx Inc. Common Stock
$6.7B5-------
KYMR
Kymera Therapeutics Inc. Common Stock
$7.0B-----27.1%0%5.230.00%
TECH
Bio-Techne Corp Common Stock
$7.1B3672.724.4----63.00%
HALO
Halozyme Therapeutics Inc. Common Stock
$7.9B7325.56.6----0.00%
Peers selected by sector + industry + nearest market cap. Best in column highlighted green, worst red.
Unlock Full Financials
Growth metrics, valuation multiples, and profitability ratios on Starter+.
Upgrade from $15/mo →
Growth73Value58Quality82Momentum61Total5
Score breakdown on Starter+
Upgrade →
Score History (90d)
Pro onlyUpgrade →
Updated 5/8/2026
Recent Alerts
No alerts yet for NBTX.
Want deep analysis?
This stock isn't in the ACCE researched universe. Browse 300+ stocks with full thesis, scores, and financial models.
Browse ACCE Indices →
Get the ACCE weekly digest
Index returns, picks recap, score movers - every Sunday. No fluff.